Efficacy and Safety of Elexacaftor-Tezacaftor-Ivacaftor in the Treatment of Cystic Fibrosis: A Systematic Review

Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) is a new CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) modulator treatment, used over the last few years, which has shown an improvement in different clinical outcomes in patients with cystic fibrosis (CF). The objective of this study was a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kapouni, Nikoletta, Moustaki, Maria, Douros, Konstantinos, Loukou, Ioanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047761/
https://www.ncbi.nlm.nih.gov/pubmed/36980112
http://dx.doi.org/10.3390/children10030554

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10047761/
https://www.ncbi.nlm.nih.gov/pubmed/36980112
http://dx.doi.org/10.3390/children10030554

Ejemplares similares